Raymond James & Associates Sells 22,528 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Raymond James & Associates lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.9% during the 2nd quarter, Holdings Channel.com reports. The fund owned 303,767 shares of the medical equipment provider’s stock after selling 22,528 shares during the quarter. Raymond James & Associates’ holdings in Intuitive Surgical were worth $135,131,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Creekmur Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares during the last quarter. MCF Advisors LLC boosted its holdings in shares of Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 40 shares during the last quarter. Able Wealth Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $28,000. Delos Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 57 shares during the last quarter. Finally, MeadowBrook Investment Advisors LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $30,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $478.98 on Monday. The stock has a market cap of $169.89 billion, a P/E ratio of 86.46, a PEG ratio of 4.97 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $482.50. The firm’s 50 day moving average price is $443.20 and its 200-day moving average price is $407.87.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter last year, the business posted $1.18 earnings per share. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Analyst Ratings Changes

A number of research firms recently issued reports on ISRG. Piper Sandler raised their price objective on shares of Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a report on Friday, July 19th. Morgan Stanley raised their price objective on shares of Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a report on Monday, July 15th. Evercore ISI dropped their price objective on shares of Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a report on Friday, July 19th. Citigroup raised their target price on shares of Intuitive Surgical from $462.00 to $512.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Finally, Robert W. Baird raised their target price on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $442.30.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,558,968.56. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, Director Amal M. Johnson sold 2,943 shares of the firm’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $5,441,507.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,558,968.56. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,309 shares of company stock valued at $6,642,470. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.